Latest filing published 06 Oct 2026 for Monte Rosa Therapeutics, Inc., €122.
Filing timeline
BuySaleInsider track record
No signal scores available.
Matthew Bowen: trading record in brief
Matthew Bowen discloses dealings in Monte Rosa Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 6 April 2026 to 5 October 2026.
No open-market purchase appears, only 1 sale worth €122. Outside the open market, there are 1 share grant.
The record was last updated on 6 October 2026 with an open-market sale (€122) in Monte Rosa Therapeutics, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Bowen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13 shares@ US$10.56Common StockSEC:0001193125-26-415540:0
- 4,300 sharesCommon StockSEC:0001193125-26-145545:0
2 of 2 declarations
